Tacalyx
FranceWho owns Tacalyx?
Tacalyx is a French Biotech company, currently owned by Boehringer Ingelheim Venture Fund since 2019 and 3 other investors.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
- ·Co-held by Boehringer Ingelheim Venture Fund, coparion, High-Tech Gruenderfonds (HTGF) and Creathor Ventures since 2019.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
More from Creathor Venture Fund IV
Other portfolio companies in the same fund.
Germany
Sweden
SwitzerlandMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Tacalyx?
Tacalyx is currently owned by Boehringer Ingelheim Venture Fund, coparion and 2 others, through Creathor Venture Fund IV, since 2019.
When did Boehringer Ingelheim Venture Fund and 3 others acquire Tacalyx?
Boehringer Ingelheim Venture Fund and 3 others acquired Tacalyx in 2019.
Who has owned Tacalyx over time?
Tacalyx has been through 4 private-equity ownership periods: Boehringer Ingelheim Venture Fund · via Boehringer Ingelheim Venture Fund · since 2019; coparion · via coparion · since 2019; High-Tech Gruenderfonds (HTGF) · via HTGF III · since 2019; Creathor Ventures · via Creathor Venture Fund IV · since 2019.